Evidence map›Paper›PMID 41748730›Full record

ArticleScientific reports2026

Incidence and risk factors of LUTS associated with benign prostatic hyperplasia among Chinese men: findings from the CHARLS cohort.

Chao Lv, Mingyue Zhao, Qingyang Meng, Zexuan Lv, Xinze Xia, Jizhang Xing, Xiaowei Hao, Yangyang Wu, Kaikai Lv, Qing Yuan and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chao Lv *Senior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Mingyue Zhao *Department of Neurosurgery, PLA Air Force Medical Center, Beijing, 100142, China. mingyzhao@fmmu.edu.cn.
Qingyang Meng *Senior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Zexuan LvSenior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Xinze XiaThe Second Clinical Medical College, Shanxi Medical University, Shanxi, 030001, China.
Jizhang XingDepartment of Urology, PLA Air Force Medical Center, Beijing, 100142, China.
Xiaowei HaoSenior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Yangyang WuSenior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Kaikai LvSenior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China.
Qing Yuan *Senior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China. qyuanmd@outlook.com.
Xu Zhang *Senior Department of Urology, 3rd Medical Centre of PLA General Hospital, Beijing, 100039, China. xzhang301@163.com.

Funding

Beijing Nova Program 20220484230National Key Research and Development Program of China 2022YFC3602900National Key Research and Development Program of China 2022YFC3602905
6 · The paper itself

Abstract

China’s rapidly aging population is increasing the prevalence and economic burden of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS-BPH). However, limited national-scale evidence exists regarding incidence, regional variation, and risk factor patterns among Chinese men. Using data from the China Health and Retirement Longitudinal Study (CHARLS), we followed 6,713 men aged ≥ 45 years who were free of LUTS-BPH at baseline (2011–2012). LUTS-BPH onset was identified through biennial surveys (2013–2018). Age- and region-specific incidence rates were calculated, and multivariable Cox proportional-hazards models were used to identify independent risk factors. During a median follow-up of seven years (38,949 person-years), 1,175 incident LUTS-BPH cases were observed, yielding an overall incidence of 30.2 per 1,000 person-years (95% CI: 28.5–31.9). Incidence increased steadily with age until 75 years and then declined slightly. Predicted cumulative risks among 45-year-old men without LUTS-BPH were 16.7%, 30.6%, and 42.2% over 10, 20, and 30 years, respectively. Significant geographical heterogeneity was observed, with higher rates in Central and southern humid regions. Independent predictors included age, body-mass index, waist circumference, education, perceived health status, smoking, napping time, and residence region.These risk factors varied across different age groups (≤ 60, 60–75, and ≥ 75). LUTS-BPH incidence in Chinese men rises with age and varies substantially by region and lifestyle. Modifiable factors such as central obesity and prolonged napping may guide early risk stratification, though causal relationships require validation in future interventional and mechanistic studies. These findings support targeted, region-specific screening strategies for China’s aging male population.

Indexed as

Lower Urinary Tract SymptomsProstatic HyperplasiaAgedChinaEast Asian PeopleHumansIncidenceLongitudinal StudiesMaleMiddle AgedRisk FactorsAging populationBenign prostatic hyperplasia (BPH)CHARLSGeographical variationIncidenceLower urinary tract symptoms (LUTS)ObesityRisk factors

Identifiers

PMID41748730
PMCPMC13046722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.